269 related articles for article (PubMed ID: 25991065)
21. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
Pandey S; Patil AT
Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
[TBL] [Abstract][Full Text] [Related]
22. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
23. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
[TBL] [Abstract][Full Text] [Related]
24. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
[No Abstract] [Full Text] [Related]
25. Ranking Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane.
Tsinman K; Tsinman O; Lingamaneni R; Zhu S; Riebesehl B; Grandeury A; Juhnke M; Van Eerdenbrugh B
Pharm Res; 2018 Jun; 35(8):161. PubMed ID: 29926245
[TBL] [Abstract][Full Text] [Related]
26. A nanosystem for water-insoluble drugs prepared by a new technology, nanoparticulation using a solid lipid and supercritical fluid.
Park JW; Yun JM; Lee ES; Youn YS; Kim KS; Oh YT; Oh KT
Arch Pharm Res; 2013 Nov; 36(11):1369-76. PubMed ID: 23780798
[TBL] [Abstract][Full Text] [Related]
27. Spherical crystallization of drugs.
Kovačič B; Vrečer F; Planinšek O
Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
[TBL] [Abstract][Full Text] [Related]
28. Downstream drug product processing of itraconazole nanosuspension: Factors influencing tablet material properties and dissolution of compacted nanosuspension-layered sugar beads.
Tan EH; Parmentier J; Low A; Möschwitzer JP
Int J Pharm; 2017 Oct; 532(1):131-138. PubMed ID: 28859940
[TBL] [Abstract][Full Text] [Related]
29. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
Wang L; Zeng F; Zong L
Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
[TBL] [Abstract][Full Text] [Related]
30. Effect of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer on bioadhesion and release rate property of eplerenone pellets.
Kendre PN; Chaudhari PD
Drug Dev Ind Pharm; 2017 May; 43(5):751-761. PubMed ID: 27494543
[TBL] [Abstract][Full Text] [Related]
31. Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs.
Keen JM; LaFountaine JS; Hughey JR; Miller DA; McGinity JW
AAPS PharmSciTech; 2018 Jul; 19(5):1998-2008. PubMed ID: 29192405
[TBL] [Abstract][Full Text] [Related]
32. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.
Patil SV; Pawar AP; Sahoo SK
Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302
[TBL] [Abstract][Full Text] [Related]
33. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
[TBL] [Abstract][Full Text] [Related]
34. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
[TBL] [Abstract][Full Text] [Related]
35. Biodegradable Porous Starch Spheres as a Novel Carrier for Enhancement of Dissolution Rate and Oral Bioavailability of Itraconazole.
Pawar J; Ali MT; Fule R; Moravkar K; Seervi M; Sathaye S; Amin P
Curr Drug Deliv; 2017; 14(7):944-954. PubMed ID: 27654575
[TBL] [Abstract][Full Text] [Related]
36. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
37. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
38. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
Linn M; Collnot EM; Djuric D; Hempel K; Fabian E; Kolter K; Lehr CM
Eur J Pharm Sci; 2012 Feb; 45(3):336-43. PubMed ID: 22172603
[TBL] [Abstract][Full Text] [Related]
39. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.
Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
Pharm Dev Technol; 2018 Jun; 23(5):454-463. PubMed ID: 27681386
[TBL] [Abstract][Full Text] [Related]
40. Soluplus
Basha M; Salama A; Noshi SH
Drug Dev Ind Pharm; 2020 Feb; 46(2):253-263. PubMed ID: 31937139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
